sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Generic Drug Market by Brand (Pure Generic and Branded Generic)...

Home / Categories / Healthcare
Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021
Generic Drug Market by Brand...
Report Code
RO1/106/1040

Publish Date
06/Oct/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global generic drugs market , 2015 - 2021 (USD Billion)

2.2. Global generic drugs market : Snapshot

Chapter 3. Generic Drugs Market  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global generic drugs market Drivers: Impact Analysis

3.3.2. increasing number of patent expiration of branded drugs and government initiatives

3.3.3. increase in prevalence of chronic diseases and emerging markets

3.4. Market Restraints


3.4.1. Global generic drugs market Restraints: Impact Analysis

3.4.2. High competition and shortage of generic drugs.

3.5. Opportunities


3.5.1. Untapped and emerging markets like India and China

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Brand segment

3.7.2. Market Attractiveness Analysis, By Therapeutic application segment

3.7.3. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global generic drugs market  Competitive Landscape


4.1. Company Market Share, 2014 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Source Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Product And Regional Expansion

4.3. Product Portfolio

Chapter 5. Global generic drugs market  Brand Analysis


5.1. Global generic drugs market : Brand Segment Overview


5.1.1. Global generic drugs market Revenue Share, By Brand Segment, 2015 And 2021

5.2. Pure generic drugs


5.2.1. Global generic drugs market for Pure generic drugs, 2015 - 2021 (USD Billion)

5.3. Branded generic drugs


5.3.1. Global generic drugs market for Branded generic drugs, 2015 - 2021 (USD Billion)

Chapter 6. Global generic drugs market  Therapeutic application Analysis


6.1. Global generic drugs market : Therapeutic application Segment Overview


6.1.1. Global generic drugs market Revenue Share, By Therapeutic application Segment, 2015 And 2021

6.2. Central nervous system (CNS)


6.2.1. Global generic drugs market For Central nervous system (CNS), 2015 - 2021 (USD Billion)

6.3. Cardiovascular


6.3.1. Global generic drugs market For Cardiovascular, 2015 - 2021 (USD Billion

6.4. Dermatology


6.4.1. Global generic drugs market For Dermatology, 2015 - 2021 (USD Billion

6.5. Oncology


6.5.1. Global generic drugs market For Oncology, 2015 - 2021 (USD Billion

6.6. Respiratory


6.6.1. Global generic drugs market For Respiratory, 2015 - 2021 (USD Billion

6.7. Others


6.7.1. Global generic drugs market For Others, 2015 - 2021 (USD Billion

Chapter 7. Global generic drugs market  Regional Segment Analysis


7.1. Global generic drugs market : Regional Overview


7.1.1. Global generic drugs market Revenue Share, By Region, 2014 And 2020

7.2. North America


7.2.1. North America generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.2.2. North America generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.2.3. U.S.


7.2.3.1. U.S. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.2.3.2. U.S. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.3. Europe


7.3.1. Europe generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)

7.3.2. Europe generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.3.3. U.K.


7.3.3.1. U.K. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.3.3.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.3.4. France


7.3.4.1. U.K. generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.3.4.2. U.K. generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.3.5. Germany


7.3.5.1. Germany generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.3.5.2. Germany generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)

7.4.2. Asia Pacific generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.4.3. China


7.4.3.1. China generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.4.3.2. China generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.4.4. Japan


7.4.4.1. Japan generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.4.4.2. Japan generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.4.5. India


7.4.5.1. India generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.4.5.2. India generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)

7.5. Latin America


7.5.1. Latin America Generic drugs market Revenue, by brand, 2015 - 2021 (USD Billion)

7.5.2. Brazil


7.5.2.1. Brazil generic drugs market Revenue, by brand classification, 2015 - 2021 , (USD Billion)

7.5.2.2. Brazil generic drugs market Revenue, by Therapeutic application 2015 - 2021 , (USD Billion)


Chapter 8. Company Profile


8.1. Teva Pharmaceutical Industries Ltd.


8.1.1. Overview

8.1.2. Financials

8.1.3. Product Portfolio

8.1.4. Business Strategy

8.1.5. Recent Developments

8.2. Novartis International AG.


8.2.1. Overview

8.2.2. Financials

8.2.3. Product Portfolio

8.2.4. Business Strategy

8.2.5. Recent Developments

8.3. Mylan N.V.


8.3.1. Overview

8.3.2. Financials

8.3.3. Product Portfolio

8.3.4. Business Strategy

8.3.5. Recent Developments

8.4. Abbott Healthcare Pvt Ltd.


8.4.1. Overview

8.4.2. Financials

8.4.3. Product Portfolio

8.4.4. Business Strategy

8.4.5. Recent Developments

8.5. Actavis pharmaceuticals Overview


8.5.1. Financials

8.5.2. Product Portfolio

8.5.3. Business Strategy

8.5.4. Recent Developments

8.6. Sun Pharmaceutical Industries Limited Overview


8.6.1. Financials

8.6.2. Product Portfolio

8.6.3. Business Strategy

8.6.4. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com